Free Trial

Beverly Hills Private Wealth LLC Buys 868 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Beverly Hills Private Wealth LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,108 shares of the healthcare conglomerate's stock after acquiring an additional 868 shares during the quarter. UnitedHealth Group comprises about 1.0% of Beverly Hills Private Wealth LLC's investment portfolio, making the stock its 18th biggest position. Beverly Hills Private Wealth LLC's holdings in UnitedHealth Group were worth $5,113,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter worth $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Robert W. Baird dropped their price target on shares of UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Morgan Stanley decreased their price target on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Truist Financial cut their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Four analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $596.86.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 1.2 %

Shares of NYSE UNH traded up $4.89 during mid-day trading on Monday, hitting $404.81. The company's stock had a trading volume of 8,146,436 shares, compared to its average volume of 4,625,259. The company's fifty day simple moving average is $494.68 and its 200-day simple moving average is $527.03. UnitedHealth Group Incorporated has a one year low of $393.11 and a one year high of $630.73. The stock has a market cap of $368.47 billion, a price-to-earnings ratio of 26.12, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the company earned $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines